Scott Gavura

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 14

Top Venues

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Pam Takhar, Marc Geirnaert, Scott Gavura, Jaclyn Beca, Rebecca E Mercer, Avram E Denburg, Caroline Muñoz, Mina Tadrous, Ambica Parmar, Francois Dionne, Darryl Boehm, Carole Chambers, Erica Craig, Maureen Trudeau, Matthew C Cheung, Joanne Houlihan, Valerie McDonald, Petros Pechlivanoglou, Marianne Taylor, Eric Wasylenko, Wiesława Dominika Wranik, Kelvin K W Chan
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration. Current oncology (Toronto, Ont.) 31 (4) (2024)
Caroline Muñoz, Xiaochen Tai, Jessica Arias, Andrea Eisen, Munaza Chaudhry, Scott Gavura, Kelvin K W Chan
Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer. Current oncology (Toronto, Ont.) 31 (3) (2024)
Pam Takhar, Marc Geirnaert, Scott Gavura, Jaclyn Beca, Rebecca E Mercer, Avram E Denburg, Caroline Muñoz, Mina Tadrous, Ambica Parmar, Francois Dionne, Darryl Boehm, Carole Chambers, Erica Craig, Maureen Trudeau, Matthew C Cheung, Joanne Houlihan, Valerie McDonald, Petros Pechlivanoglou, Marianne Taylor, Eric Wasylenko, Wiesława Dominika Wranik, Kelvin K W Chan
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration. Current oncology (Toronto, Ont.) 31 (4) (2024)
Caroline Muñoz, Xiaochen Tai, Jessica Arias, Andrea Eisen, Munaza Chaudhry, Scott Gavura, Kelvin K W Chan
Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer. Current oncology (Toronto, Ont.) 31 (3) (2024)
Qi Guan, Suriya J Aktar, Reka E Pataky, Mariet Mathew Stephen, Maud Marques, Karen Gambaro, Kahina Rachedi, Katharina Forster, Samara Strub, David Stock, Louis de Léséleuc, Winson Y Cheung, Stuart J Peacock, Christie Farrer, Scott Gavura, Mina Tadrous, Robert C Grant, Kelvin K W Chan
Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada. Current oncology (Toronto, Ont.) 31 (6) (2024)
Qi Guan, Suriya J Aktar, Reka E Pataky, Mariet Mathew Stephen, Maud Marques, Karen Gambaro, Kahina Rachedi, Katharina Forster, Samara Strub, David Stock, Louis de Léséleuc, Winson Y Cheung, Stuart J Peacock, Christie Farrer, Scott Gavura, Mina Tadrous, Robert C Grant, Kelvin K W Chan
Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada. Current oncology (Toronto, Ont.) 31 (6) (2024)
Caroline Muñoz, Xiaochen Tai, Jessica Arias, Andrea Eisen, Munaza Chaudhry, Scott Gavura, Kelvin K W Chan
Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer. Current oncology (Toronto, Ont.) 31 (3) (2024)
Pam Takhar, Marc Geirnaert, Scott Gavura, Jaclyn Beca, Rebecca E Mercer, Avram E Denburg, Caroline Muñoz, Mina Tadrous, Ambica Parmar, Francois Dionne, Darryl Boehm, Carole Chambers, Erica Craig, Maureen Trudeau, Matthew C Cheung, Joanne Houlihan, Valerie McDonald, Petros Pechlivanoglou, Marianne Taylor, Eric Wasylenko, Wiesława Dominika Wranik, Kelvin K W Chan
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration. Current oncology (Toronto, Ont.) 31 (4) (2024)
Pam Takhar, Marc Geirnaert, Scott Gavura, Jaclyn Beca, Rebecca E Mercer, Avram E Denburg, Caroline Muñoz, Mina Tadrous, Ambica Parmar, Francois Dionne, Darryl Boehm, Carole Chambers, Erica Craig, Maureen Trudeau, Matthew C Cheung, Joanne Houlihan, Valerie McDonald, Petros Pechlivanoglou, Marianne Taylor, Eric Wasylenko, Wiesława Dominika Wranik, Kelvin K W Chan
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration. Current oncology (Toronto, Ont.) 31 (4) (2024)
Caroline Muñoz, Xiaochen Tai, Jessica Arias, Andrea Eisen, Munaza Chaudhry, Scott Gavura, Kelvin K W Chan
Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer. Current oncology (Toronto, Ont.) 31 (3) (2024)
Qi Guan, Suriya J Aktar, Reka E Pataky, Mariet Mathew Stephen, Maud Marques, Karen Gambaro, Kahina Rachedi, Katharina Forster, Samara Strub, David Stock, Louis de Léséleuc, Winson Y Cheung, Stuart J Peacock, Christie Farrer, Scott Gavura, Mina Tadrous, Robert C Grant, Kelvin K W Chan
Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada. Current oncology (Toronto, Ont.) 31 (6) (2024)
Ambica Parmar, Wei Fang Dai, Francois Dionne, Marc Geirnaert, Avram E Denburg, Tarry Ahuja, Jaclyn Beca, Sylvie Bouchard, Carole Chambers, Melissa J Hunt, Donald Husereau, Elena Lungu, Valerie McDonald, Rebecca E Mercer, Gunita Mitera, Caroline Muñoz, Rohini Naipaul, Stuart J Peacock, Tanya Potashnik, Mina Tadrous, Pam Takhar, Marianne Taylor, Maureen Trudeau, Danica Wasney, Scott Gavura, Kelvin K W Chan
Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration. Current oncology (Toronto, Ont.) 30 (4) (2023)
Ambica Parmar, Wei Fang Dai, Francois Dionne, Marc Geirnaert, Avram E Denburg, Tarry Ahuja, Jaclyn Beca, Sylvie Bouchard, Carole Chambers, Melissa J Hunt, Donald Husereau, Elena Lungu, Valerie McDonald, Rebecca E Mercer, Gunita Mitera, Caroline Muñoz, Rohini Naipaul, Stuart J Peacock, Tanya Potashnik, Mina Tadrous, Pam Takhar, Marianne Taylor, Maureen Trudeau, Danica Wasney, Scott Gavura, Kelvin K W Chan
Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration. Current oncology (Toronto, Ont.) 30 (4) (2023)
Ambica Parmar, Wei Fang Dai, Francois Dionne, Marc Geirnaert, Avram E Denburg, Tarry Ahuja, Jaclyn Beca, Sylvie Bouchard, Carole Chambers, Melissa J Hunt, Donald Husereau, Elena Lungu, Valerie McDonald, Rebecca E Mercer, Gunita Mitera, Caroline Muñoz, Rohini Naipaul, Stuart J Peacock, Tanya Potashnik, Mina Tadrous, Pam Takhar, Marianne Taylor, Maureen Trudeau, Danica Wasney, Scott Gavura, Kelvin K W Chan
Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration. Current oncology (Toronto, Ont.) 30 (4) (2023)

Scott Gavura.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Scott Gavura